Roche Receives Approval For Laboratory Based Elecsys SARS-CoV-2 Antigen Test To Facilitate High-Volume Testing In The Country

* The Elecsys SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in the diagnosis of active SARS-CoV-2 infection

* Antigen tests can complement PCR tests and help governments and healthcare systems to increase the testing capacities they need to manage SARS-CoV-2.

* The test allows cost and error reduction due to removal of manual handling as well as fast turn-around times and high test throughput.

* The test is the latest addition to Roche’s comprehensive COVID-19 portfolio and can help in the management of patients for optimal care delivery

Roche announced today that it has launched a high-throughput SARS-CoV-2 antigen test as an aid in the diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections. The laboratory based Elecsys SARS-CoV-2 Antigen test had earlier received CE mark has recently obtained the import license from CDSCO

The automated lab based antigen test could be useful in diagnosing symptomatic patients and exposed asymptomatic individuals. In addition, it will facilitate frequent screening of individuals in high-risk settings.

Roche’s Elecsys SARS-CoV-2 Antigen test is an immunoassay intended for the qualitative detection of SARS-CoV-2 present in the respiratory tract including nasopharynx and oropharynx. The Elecsys SARS-CoV-2 Antigen test is performed by healthcare professionals and could be used as an alternative or in conjunction with PCR testing. This test will be highly beneficial in reducing the burden on PCR testing, it can help provide faster reporting and could also be used in setups wherein the PCR testing is either limited or not available, thus reducing turnaround time for samples. In symptomatic individuals, a positive result with the Elecsys SARS-CoV-2 Antigen test indicates an active SARS-CoV-2 infection with a likelihood of 94.5%. A negative result may require to be confirmed with a PCR test or repeated (antigen test) after one to two days, if other clinical indications point to a SARS-CoV-2 infection.

Narendra Varde, Managing Director, Roche Diagnostics India and Neighboring Markets, “Robust diagnostic testing capacity is the bedrock to manage COVID-19 and contain community spread. With >2000 instrument installations across India, the high accuracy, high-throughput laboratory antigen test will give a vital boost to our testing capabilities supporting the Indian healthcare system in the diagnosis of SARS-CoV-2 infections. The launch of this test is the result of Roche Diagnostics’ unwavering commitment to help healthcare systems across the world contain SARS CoV.”

Dr. Nilesh Shah, President and Chief of Science & Innovation, Metropolis Healthcare Ltd, “Roche ECLIA antigen assay is a next generation test that overcomes major limitations of rapid antigen tests. Longer sample stability, no subjectivity, full automation and better sensitivity make the assay a top choice for COVID-19 testing. As a user, I would prefer positioning this test to be the primary choice for patients, while symptomatic negatives can be tested by RT-PCR as a reflex test".

Dr Nitin M Chavan, Consultant Pathologist, Lilavati Hospital and Research Center, "The automated SARS-CoV-2 antigen tests can be a valuable help in scaling up COVID-19 diagnostic testing in India. With sophisticated technology, high accuracy, fast turnaround time and easy accessibility, these tests are apt to diagnose individuals with symptoms of COVID-19, contact tracing of asymptomatic individuals and for surveillance testing in settings with high risk of infection".

The Elecsys SARS-CoV-2 Antigen test is a highly accurate test for patients with signs and symptoms suggestive of COVID-19, or people with either known or suspected exposure to SARS-CoV-2. In clinical studies, the Elecsys SARS-CoV-2 Antigen test showed a 94.5% sensitivity across 390 PCR confirmed symptomatic individuals* and a 99.9% specificity across 2747 PCR negative symptomatic, exposed and screening individuals.

The Elecsys SARS-CoV-2 Antigen immunoassay runs on all cobas e immunochemistry analysers which are widely available in India and allow for these test to be run alongside other COVID-19 and other infectious diseases markers available from Roche, which run on the cobas e systems. This test, running on the electrochemiluminescence technology, ensures high accuracy and precision in testing. These fully automated systems can provide test results in 18 minutes for a single test (excluding time for sample collection, transport, and preparation), with a throughput of up to 300 tests per hour from a single analyser, depending on the analyser[i].

About antigen testing

An antigen test detects proteins which are structural or functional components of a pathogen and are thus very specific to that pathogen.[ii]  In this case, the test would provide a qualitative “yes/no” answer on the presence of the pathogen in the patient sample. If the target antigen is present in sufficient concentrations in the sample, it will bind to specific antibodies and generate a positive result, indicating an active infection.[iii]

In general, antigen tests have a high specificity, though are not as sensitive as PCR tests that amplify the target viral DNA or RNA sequence in order to generate a quantifiable signal to indicate the presence of the virus in a sample. Therefore, to make up for the potential decrease in sensitivity of an antigen test, negative results should be analysed together with additional patient factors, such as COVID-19 exposure history, clinical symptoms, additional test results to help guide the diagnosis and subsequent treatment of the patient.

[i] Full specifications of the Roche immunoassay systems, including throughput, can be found on our diagnostics.roche website

[ii] European Centre for Disease Prevention and Control. Diagnostic testing and screening for SARS-CoV-2. 2020. https://www.ecdc.europa.eu/en/covid-19/latest-evidence/diagnostic-testing Accessed July 2020

[iii] https://www.who.int/news-room/commentaries/detail/advice-on-the-use-of-point-of-care-immunodiagnostic-tests-for-covid-19

* The performance evaluation was performed in symptomatic individuals with a cobas® SARS-CoV-2 RT-PCR Target 2 Ct value <30.

**availability subjected to regulatory approvals

About Roche Diagnostics India

Roche Diagnostics India Pvt. Ltd. established in the year 2002 has offices located in Chennai, Delhi, Kolkata and Mumbai with over 400 employees. Our broad range of innovative diagnostic tests and systems play a pivotal role in the groundbreaking area of integrated healthcare solutions and cover early detection, targeted screening, evaluation and monitoring of disease. Roche Diagnostics India works with the objective of “Doing now what patients need next”, thus preparing for the nation’s future healthcare needs.

All trademarks used or mentioned in this release are protected by law.

Nutanix Launches Service Provider Program Expanding Delivery Of Hybrid And Multicloud Solutions

* Expanded Nutanix Elevate Partner Program Drives Greater Revenue and Profitability for Service Providers

Nutanix (NASDAQ: NTNX), a leader in private, hybrid and multicloud computing, today announced the launch of the Nutanix Elevate Service Provider Program, further extending the benefits of the Elevate Partner Program to now include service providers globally. The program empowers service provider partners – including managed and cloud service providers – to build highly-differentiated hybrid and multicloud services, delivering increased profitability and faster time-to-market.

As many organizations look for opportunities to simplify their IT operations, IDC forecasts the managed cloud services market to grow to $101.1B by 2024*. With this opportunity, comes the challenge of service providers meeting increasingly individualized customer demands while staying profitable. The Nutanix Elevate Service Provider Program helps service providers improve margins and agility by addressing the lock-in and minimum commitment requirements encountered in traditional service provider vendor models and programs. 

“As the demand for managed and cloud services surges, service providers are uniquely positioned to assist an organization’s growth, optimization initiatives, and digital transformation needs,” said Christian Alvarez, SVP Worldwide Channels at Nutanix. “Through the Nutanix Elevate Service Provider Program, we are rewarding our partners’ commitment in delivering high value IT cloud service offerings​ and helping them maximize profitability and increase their revenue growth potential through premium offerings.”

Nutanix Elevate Service Provider Program Details

This service provider program adds two partnership levels to Nutanix Elevate: Authorized Service Provider and Professional Service Provider. Authorized Service Providers will include partners new to Nutanix or those delivering Nutanix services to small to mid-market organizations. Professional Service Provider will deliver differentiated services for enterprise organizations. Partners who join the program will be able to take advantage of all the benefits outlined in the Elevate Service Provider Program Guide including training, Not For Resale (NFR) and Nutanix XLAB software licenses, and enablement support. Professional Service Provider partners will be able to take advantage of expanded support from Nutanix including marketing materials, potential market development funds, sales tools, goal-based financial incentives and rebates, and personalized insights in the Nutanix Partner Portal.

Key advantages of Nutanix solutions and Elevate Service Provider Program include:

Improved Bottom Line: Simplified pricing options, no minimum commitment levels​ or mandatory product purchases help deliver increased profitability for service providers. Nutanix service providers also benefit from significantly lower management overhead with Nutanix, compared to competitors, ultimately delivering a highly capable and cost-effective HCI solution.

Increased Top Line and Fast​er Time-to-Market: The simplicity of Nutanix solutions can also help deliver faster time-to-market thanks to more than 80% faster deployment. Nutanix service providers can also onboard and rapidly scale new services including private, hybrid and multicloud, Desktop as a Service (DaaS), Disaster Recovery as a Service (DRaaS), Database as a Service (DBaaS), and more. Additionally, Nutanix software licenses can be used by service providers at their customer’s site, in the service provider’s environment, or on Nutanix Clusters running in public cloud environments - including AWS, AWS GovCloud and with support for Microsoft Azure under development - giving their customers a fast path to hybrid cloud.

Simplicity: A hallmark of Nutanix solutions, and a key driver behind the company’s average NPS score of 90 for the last seven years, is simplicity. Service providers will be able to deliver IT services, at any scale, with simple one-click deployment, upgrades, scaling, self-healing capabilities, troubleshooting and more with Nutanix. This will allow Nutanix service provider partners to realize nearly 60% more efficient IT infrastructure management, freeing up significant time to focus on innovation and supporting broader business priorities. Additionally, service providers can take advantage of auto-metering, enabling them to provide granular billing to their customers.

Nutanix is running a Service Provider Starter Pack promotional offer for new partners joining the Elevate Service Provider Program. This promotional offer includes training, certification and the right Nutanix software to help partners bring their differentiated services to production and start generating revenue. This offer is available immediately.

The Nutanix Elevate Service Provider program is available now to providers worldwide. More information on how to sign up, accompanying benefits, and the program guide are available at https://www.nutanix.com/partners/become-a-partner. Partners can also learn more about the program by signing up for the upcoming webinar on June 30, 2021, here.

Supporting quotes about the launch of the NESPP: 

Yotta: “Yotta chose Nutanix to power our managed private cloud services because of its well-architected platform and portfolio. Nutanix delivers performance, security, and control at scale for our customer’s mission critical business applications. We are excited for the Nutanix Elevate Service Provider Program as we continue to expand our partnership to deliver leading data center services to our customers at the most reasonable costs.” - Sunil Gupta, Managing Partner & CEO, Yotta

Cyxtera: “Thanks to the successful partnership we’ve built with Nutanix, Cyxtera’s customers can now deploy Nutanix Cloud Platform on our automated, on-demand infrastructure platform in more than half of our world-class datacenters. The Nutanix Elevate Service Provider Program offers us the ability to continue growing together. We are very excited to provide our customers increased flexibility by eliminating the complexities of procurement, logistics, and capital equipment management as a strategic Nutanix partner for hosted private infrastructure via Cyxtera’s Enterprise Bare Metal offering.” – Russell Cozart, Senior Vice President of Marketing and Product Strategy, Cyxtera

HKT: “At HKT, we are continuously enhancing our managed service offerings of integrated solutions to support the unique business needs of Hong Kong enterprises. Nutanix is a trusted and reliable partner, which performs admirably in terms of technology and support. With the new Nutanix Elevate Service Provider Program, together we will be able to deliver greater value and innovation for our customers’ digital transformation journey, in a way that can best meet their business demands across hybrid and multicloud.” – Tom Chan, Managing Director of HKT Commercial Group, HKT

OneNeck: OneNeck IT Solutions partnered with Nutanix to power our ReliaCloud Edge, a hosted private cloud, because Nutanix technologies provided the scalability to meet our customer’s IT needs with the reliability, security and high performance that their business demands.  As we continue to expand our partnership with new services powered by Nutanix, the option to join the Nutanix Elevate Service Provider Program offers us additional benefits that will help us expand our customers' ability to consume our data center services.” – Ted Wiessing, SVP Technology and Chief Security & Privacy Officer, OneNeck

OVH: “Partnering with Nutanix is a significant step forward to better address hosted private cloud’s growing demand with a highest level of technical solutions. Today we are announcing a great partnership between OVHcloud and Nutanix to offer a breadth of infrastructure options, with an eye toward future innovations, for our customers. Leading hosted private cloud solutions offered by OVHcloud continue to gain momentum in the market. Together with Nutanix and the new Nutanix Elevate Service Provider Program, OVHcloud is embarking on the mission to deliver next-generation hosted private cloud service offerings with a strong feature set offering performances and security that address a broad range of use cases for companies of all sizes at the best price.” – Michel Paulin, CEO, OVHcloud

TierPoint: “TierPoint is all about meeting our customers where they are on their journeys to IT transformation and delivering successful business outcomes to them. We picked Nutanix to build managed private cloud and cloud-to-cloud recovery solutions because of the simplicity, stability, and scalability of the Nutanix platform. Tierpoint joining the Nutanix Elevate Service Provider Program will make it even easier to add and deliver services that power our customer’s success and will continue to allow us to work hand-in-hand to find ways to advance the objectives of our shared clients.” – Brian Anderson, VP of Product Development, TierPoint

*Source: IDC, Worldwide Managed Cloud Services Forecast, 2020–2024: An Extraction View of Technology Outsourcing Services Markets (IDC #US45926720, September 2020)

Emirates SkyCargo Expands Pharma Cool Chain Infrastructure In Dubai, Enhancing Vaccine Transport Capabilities

Emirates SkyCargo is further strengthening its temperature sensitive pharma and vaccine handling capabilities in Dubai with the extension of its fully automated cool room with 94 airline pallet positions at its EU GDP certified dedicated pharma facility at Dubai International Airport.

The extended cool room will provide an additional 2600 square metres of temperature controlled environment (2-25 degrees Celsius) for the storage and handling of vaccines and other pharmaceuticals at Emirates SkyCargo’s purpose built GDP certified facility, reinforcing the carrier’s position as an industry leader for the air transportation of pharmaceuticals and providing additional capacity at its Dubai hub to meet the growing demand for transportation of Covid-19 vaccines. The new extension can hold an estimated 60-90 million doses of Covid-19 vaccines at one time.

Transportation of Covid-19 vaccines

Emirates SkyCargo continues to play a leading role in the international distribution of Covid-19 vaccines having transported over 75 million doses of Covid-19 vaccines on more than 250 flights to over 60 destinations since late 2020.

"Emirates SkyCargo is proud to have flown over 350 tonnes of Covid-19 vaccines around the world, delivering much needed support to communities that are still heavily impacted by the current wave of the pandemic. However, we are always looking ahead and we anticipate that there will be an increase in demand to transport vaccines to developing nations during the second half of the year. Already, we have seen a ramping up of Covid-19 vaccine volumes that were transported over the last few weeks in line with increased manufacturing. We expect to reach the 100 million doses milestone well before the end of this month," said Nabil Sultan, Emirates divisional senior vice president, Cargo.

"The last six months have been a valuable and mutual learning experience for Emirates SkyCargo and as well for pharmaceutical manufacturers and our logistics partners. We have been able to apply these learnings to make the process of vaccine transportation faster and more efficient, providing a valuable boost to the next phase of Covid-19 vaccine transportation, as well as for other temperature sensitive pharma products in the future" added Sultan.

Emirates SkyCargo was one of the first air cargo carriers to begin extensive preparations during the early stages of the pandemic for the transportation of Covid-19 vaccines. In October 2020, the carrier announced the setting up of a dedicated GDP certified airside hub in Dubai for transporting Covid-19 vaccines. The carrier has over 20,000 sq metres of EU GDP certified cool chain infrastructure for storing and handling Covid-19 vaccines in Dubai. Emirates SkyCargo also has more than 50 cool dollies dedicated for pharmaceuticals at its hub protecting temperature sensitive shipments such as vaccines during transit between the aircraft and the cargo terminal.

In January 2020, Emirates SkyCargo joined hands with DP World, International Humanitarian City and Dubai Airports to form the Dubai Vaccine Logistics Alliance aimed at rapidly transporting Covid-19 vaccines through Dubai to developing countries. This was shortly followed up in February 2020 with an MoU with UNICEF to expedite the transportation of Covid-19 vaccines under the COVAX initiative.

In addition to Covid-19 vaccines, Emirates SkyCargo has transported thousands of tonnes of other essential commodities such as PPE, pharmaceuticals and related supplies on its flights. The carrier recently set up a humanitarian airbridge initiative to transport urgent Covid-19 relief items to India. Under the initiative, the air cargo is offering any available cargo capacity on its flights from Dubai to nine destinations in India, free of charge for NGOs for transporting medical and relief items.

SaaS, Cloud To Be Major Growth Drivers For Trend Micro, India In 2021

* Launches ‘Partner Ninja’ program, rewards & benefits for its channels, at the Partner Day  

Trend Micro Incorporated (TYO: 4704; TSE: 4704), a global leader in cybersecurity solutions, recently held its virtual regional partner conference, Partner Day 2021. The event addressed a gamut of issues ranging from new attack vectors, increasing DevOps velocity, complex compliance to challenges pertaining to too many security tools etc. The company also shared its focus strategies for the year, to pivot around Trend Micro Vision One Threat Defence Platform leveraging advanced XDR capabilities and Cloud One Security Services Platform for Cloud Builders, which is a Cloud-native, SaaS-based platform with the most extensive set of cloud security services. The company also mentioned that Software-as-a-service (SaaS) and cloud have become the major growth drivers for its business in India. 

In India, the company has witnessed a significant growth across its enterprise and government verticals. In India, Trend Micro has one of the largest teams in cybersecurity, serving enterprises across different verticals.   

Vijendra Katiyar, Country Manager, India & SAARC, Trend Micro said, “Notwithstanding the pandemic and its impact on the economy, India has been as one of the fastest growing markets for us in the region. I would like to express my gratitude and thank all the partners who have shown confidence in Trend Micro and contributed to this growth of ours’. Our Partner Day gives us yet another opportunity to reward as well as to empower our partners to grow alongside us and take our exciting next-gen offerings to the market, whether it’s our Trend Micro Vision One or Cloud One Security Services. It’s also a time for us to come together and chart out our strategic plans and delve on the focus areas for the coming year.” 

He further added, “Customers are looking for service providers beyond deployment stage to ensure that solutions are running smoothly and monitored well. The scope of services has to ensure that customers take full benefit of the solutions. So, Trend Micro Vision One provides a platform for partners to weave specialized services to increase value proposition to the customers.” 

As part of the partner program update, Trend Micro shared elaborate insights around its latest ‘Partner Ninja’ program offering for their partner community, with a multi-pronged objective which includes - to develop experts (Ninjas) within the partner community, to make the selected partners as an extended arm of the company, and finally, to increase the number of certified engineers trained on Trend Micro products.

Tom Cheeran, Director - Channel, India & SAARC, Trend Micro said, “We have always been a channel-focused company and try to deliver all our solutions through the channel. Keeping the channels at the core of what we do, our ‘Partner Ninja’ is an exciting competency enhancement program that aims to further empower and equip our channel community. Apart from this, there would be a host of partner program benefits that partners could avail, i.e.  – skill enhancement with TRENDs CAMPUS Program and access to educational content on the Partner Portal etc.” 

About Trend Micro  

Trend Micro, a global cybersecurity leader, helps make the world safe for exchanging digital information. Fueled by decades of security expertise, global threat research, and continuous innovation, Trend Micro's cybersecurity platform protects hundreds of thousands of organizations and millions of individuals across clouds, networks, devices, and endpoints. As a leader in cloud and enterprise cybersecurity, the platform delivers a powerful range of advanced threat defence techniques optimized for environments like AWS, Microsoft, and Google, and central visibility for better, faster detection and response. With 7,000 employees across 65 countries, Trend Micro enables organizations to simplify and secure their connected world.

Manipal Academy Of Higher Education To Organise Vaccination Drive For All Its Students Free Of Cost

* Over 25,000 students to be inoculated free of cost

Manipal Academy of Higher Education in a bid to ensure safety for all its students will be organising a free vaccination drive for all the students across its institutions. In this endeavour MAHE plans to vaccinate 25,000 students. This measure will ensure that students of MAHE will get easy access to COVID Vaccine and will ensure safety of all its students in the campus. MAHE administration will bear the entire cost of this vaccination drive for its students.

Sharing his thoughts, Dr HS Ballal, Pro Chancellor of Manipal Academy of Higher Education “We are delighted to organise vaccination drive for all our students. In fact MAHE is in the forefront to set up the drive to ensure safety for all its students, this will be a great milestone for MAHE. The drive will be organised in line with the Government of India protocols. It is important for everyone to get vaccinated in order to fight the virus and contain the spread “

Lt. Gen. (Dr.) M. D. Venkatesh, Vice Chancellor, Manipal Academy of Higher Education (MAHE) said, “It is with immense pleasure we announce the free vaccination programme for all our students at MAHE. Students are the backbone of MAHE and it is our responsibility to immunise them to safe guard their health and wellness. In this COVID Pandemic that is ravaging the entire world, vaccination and COVID appropriate measures are the only things that keep everyone safe. Our endeavour is to help speedy vaccination of our students and do our bit to the national effort of vaccination for all.  

Dr Narayana Sabhahit, Registrar, Manipal Academy of Higher Education, said, “We are happy to extend vaccination support to all our students. At MAHE, we have always provided help and support to our students under all circumstances especially in the challenging times of the Pandemic. We will organise a seamless drive for our students which will ensure they get their jabs as per the guidelines of the Ministry.  We wish all our students good health and the vaccination will secure them from COVID infection and we look forward to the drive “

MAHE has already started vaccinating students who are present on campus in the hostels. The drive will also help all our students who are residing in and around Manipal. These students are requested to contact their respective institutions to get their vaccinations. This effort will continue to vaccinate all other students as and when they return to the campus.

Shyam Metalics & Energy Limited Public Offering Of Equity Shares Opening From June 14-16, 2021

* Price Band of Rs. 303 – Rs. 306 per equity share of face value of Rs. 10 each (“Equity Share”)

* Bid/Offer Opening Date – Monday, June 14, 2021 and Bid/Offer Closing Date – Wednesday, June 16, 2021

* Minimum Bid Lot is 45 Equity Shares and in multiples of 45 Equity Shares thereafter

* The Floor Price is 30.3 times the face value of the Equity Shares and the Cap Price is 30.6 times the face value of the Equity Shares.

Shyam Metalics and Energy Limited (“SMEL”, including its subsidiaries and associates, the “Group”) is proposing to open the Bid/Offer period in relation to its initial public offering of Equity Shares (the “Offer”/ “IPO”) on Monday, June 14 2021 and close the Bid/Offer period on Wednesday, June 16, 2021. The price band for the Offer has been decided at Rs. 303 – Rs. 306 per Equity Share. The Company and the Selling Shareholders have, in consultation with the book running lead managers (the “BRLMs”), considered participation by Anchor Investors, which participation shall be one Working Day prior to the Bid/Offer Opening Date, i.e. Friday, June 11, 2021.

The total issue size is upto Rs. 909 crore with a fresh issuance of Equity Shares, aggregating up to Rs. 657 Cr and an offer for sale of Equity Shares aggregating up to Rs. 252 cr, by the Selling Shareholders. The company proposes to utilise the Net Proceeds from the Fresh Issue towards repayment or prepayment of up to Rs 470 crs of its debt and that of its subsidiary, Shyam SEL and Power Limited and for other general corporate purposes.

The Group is a producer of intermediate and long steel products, such as, iron pellets, sponge iron, steel billets, TMT, structural products, wire rods, and ferro alloys products with a specific focus on high margin products, such as, customised billets and specialised ferro alloys for special steel applications. The Group is currently in the process of further diversifying its product portfolio by entering into the segments, such as, pig iron, ductile iron pipes and aluminium foil. The Group’s key strength lies in its integrated operations across the steel value chain and strategic locations of its manufacturing plants in Odisha and West Bengal which are well connected by railways, roadways and ports in the eastern region of India and are supported by infrastructure in terms of captive railway sidings and captive power plants.

The Group’s manufacturing plants at Sambalpur and Jamuria are forward and backward integrated, and the Group is present across steel value chain, offers a diversified product mix, and has strategic locational advantage. In the nine months ended December 31, 2020, power units produced from the Group’s captive power plants accounted for 79.58% of their total power units consumed. The Group has a wide distribution network partnered through 42 distributors across 13 states and one union territory in India, as of December 31, 2020. The Group’s domestic customers include Jindal Stainless Limited, Jindal Stainless (Hisar) Limited, and Rimjhim Ispat Limited and international customers include Norecom DMCC, Norecom Limited, POSCO International Corporation, World Metals & Alloys (FZC), Traxys North America LLC, JM Global Resources Limited, Goenka Steels Private Limited and Vijayshri Steel Private Limited.

ICICI Securities Limited, JM Financial Limited, Axis Capital Limited, IIFL Securities Limited and SBI Capital Markets Limited are the BRLMS to the Offer.

The Offer is being made in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended (“SCRR”), read with Regulation 31 of the SEBI ICDR Regulations. The Offer is being made in accordance with Regulation 6(1) of the SEBI ICDR Regulations, through the Book Building Process wherein not less than 15% of the Offer shall be available for allocation on a proportionate basis to Non-Institutional Bidders and not less than 35% of the Offer shall be available for allocation to Retail Individual Bidders in accordance with the SEBI ICDR Regulations subject to valid Bids being received from them at or above the Offer Price. The portion of the Offer being up to 300,000 Equity Shares, which shall not exceed 5% of the post Offer Equity Share capital of our company, is available for allocation to Eligible Employees, on a proportionate basis.

Muscle And Strength India Comes Forward To Help The Needy During The Covid 19 Pandemic

The COVID-19 crisis has brought out the best and the worst in humanity. Amid the second wave that brings with it a flood of stories of despair, few humanitarians are churning out a counter-narrative of hope, unity and resilience. These people have risen to the occasion, and ensured no one on the road goes hungry or unmasked and are making a difference. In its effort to support the cause, Muscle and Strength India, one of the country’s leading retailers of fitness supplements & nutritional products have come forward to help the needy in these testing times. The company has helped under-privileged people by distributing free food, dry rations, other essentials, and also N95 masks etc. They have also distributed masks & immunity booster tablets to delivery boys for their health & safety.

As the city battles the second wave of the Covid-19 pandemic, many organizations, volunteer groups, NGO’s etc have sprung into action in offering support to those infected and also homeless people, daily wage labourers, domestic workers, roadside dwellers and low-income workers, thus keeping the spirit of humanity alive with their effort.

“Corona pandemic is turning life upside down for many. With the rise in the number of Covid-19 cases, many states imposed lockdowns. While many of us are working from home, spending quality time with our family, at the comfort of our homes during this lockdown, there are many people who aren’t as fortunate. There are scores of unorganised workers & poor people who depend on daily-based work to meet their basic needs and hence a lockdown meant an immediate pause in their current livelihood. Hence we feel that everybody has to come together to provide a helping hand to the needy in these distressing times of the pandemic.” said Mr. Praveen Chirania, Founder, Muscle and Strength India, who has been distributing the relief materials to the needy personally.

"The same set of people, whom we served earlier were waiting for us with hopeful eyes. We felt so proud and content. By serving food, we not only satiate their hunger but also give them confidence to live. Even as we are all being tested in ways we could never have imagined, there are ways in which we can help out. It may not be a big gesture, but a small act of kindness can brighten up someone’s day, and create a sense of community, support and hope. Going forward, we at Muscle and Strength India will continue to support our initiative and hope to help many more people,” added Praveen.

Muscle and Strength India offers a comprehensive range of genuine high-quality fitness supplement and nutritional products across categories such as proteins, vitamins, minerals and herbal supplements etc manufactured by international fitness brands under a single roof. Muscle and Strength India, which currently has 15 stores spread across multiple cities has the widest range with over 1000 fitness supplements and nutrition products from 42+ brands. The sole aim of the company is to make health and wellness a priority for all.